DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 121 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2015. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $605,000 | -62.2% | 153,252 | +0.3% | 0.00% | -50.0% |
| Q3 2016 | $1,602,000 | -25.6% | 152,732 | +3.4% | 0.00% | -33.3% |
| Q2 2016 | $2,153,000 | -14.9% | 147,646 | +12.3% | 0.00% | 0.0% |
| Q1 2016 | $2,529,000 | -18.4% | 131,426 | +2.5% | 0.00% | -25.0% |
| Q4 2015 | $3,098,000 | -0.7% | 128,219 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $3,121,000 | +27.9% | 127,170 | +22.1% | 0.00% | +33.3% |
| Q2 2015 | $2,441,000 | +14.1% | 104,195 | +9.3% | 0.00% | 0.0% |
| Q1 2015 | $2,139,000 | +45.8% | 95,366 | +9.6% | 0.00% | +50.0% |
| Q4 2014 | $1,467,000 | – | 87,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |